Centromeres are chromosomal loci that drive chromosome segregation during mitosis.
Introduction
Accurate segregation of newly replicated chromosomes during mitosis is essential for the maintenance of genome integrity. Central to preserving fidelity of this process is the kinetochore which forms the attachment site for spindle microtubules and is required for chromosome movement and mitotic checkpoint signaling (Cheeseman and Desai, 2008 ).
The centromere is a unique constitutive chromatin domain that assembles the kinetochore during mitosis and is essential for mitotic progression. Centromeres are propagated epigenetically, largely independent of any particular DNA sequence (Allshire and Karpen, 2008; Amor et al., 2004) . Key to the maintenance of centromere identity is the specific assembly of the histone H3 variant Centromere Protein A (CENP-A) into centromeric nucleosomes (Silva and Jansen, 2009; Black and Bassett, 2008) .
Inheritance and replication of this mark is essential to ensure epigenetic propagation of centromere identity. Indeed, CENP-A containing nucleosomes are extremely stable and maintained throughout the cell cycle, being redistributed only during S phase (Jansen et al., 2007; Hemmerich et al., 2008; Shelby et al., 2000; Régnier et al., 2005) . Importantly, centromeric chromatin replication is uncoupled from centromeric DNA replication and, at least in metazoans is restricted to late mitosis / early G1 phase of the cell cycle (Jansen et al., 2007; Schuh et al., 2007; Hemmerich et al., 2008) . Assembly strictly depends on passage through mitosis (Jansen et al., 2007; Schuh et al., 2007) which ensures tight coupling of centromere duplication to cell cycle progression. However, the mitotic trigger that initiates centromere propagation has not been identified. Possible candidates for this have been previously proposed ( Figure 1A ), including changes in chromatin architecture (Jansen et al., 2007; Mellone and Allshire, 2003) , APC-mediated destruction of a specific inhibitor of CENP-A assembly (Erhardt et al., 2008) , or assembly of a proper kinetochore-microtubule interface (Allshire and Karpen, 2008; Jansen et al., 2007) . Here, we sought to identify the molecular signal that temporally controls CENP-A assembly. Our results point to a simple mechanism that excludes the need for any active involvement of mitosis in subsequence CENP-A assembly, other than the concomitant down regulation of Cdk activity upon mitotic exit.
Results

CDK inhibition is sufficient to induce CENP-A assembly
In order to identify the molecular mechanism controlling the unusual timing of CENP-A assembly, we employed SNAP-based quench-chase-pulse labeling [see Methods and (Jansen et al., 2007) ] to uniquely and directly track the fate of nascent proteins. One defining feature of mitotic exit is APC mediated destruction of cyclin B and concomitant loss of associated cyclin dependent kinase (Cdk1) activity. We therefore hypothesized that the CENP-A assembly process might be controlled directly by Cdk activity, without a strict need for APC activation, destruction of APC targets apart from the Cdk activator cyclin B, or any other aspect of mitosis. To test this hypothesis, we synchronized HeLa cells in G2 phase, upon which a nascent pool of CENP-A-SNAP, synthesized during the preceding S phase, was fluorescently pulse labeled. A brief (1 hour) treatment with the pan-Cdk inhibitors Roscovitine or Purvalanol A induced assembly in nearly half the G2 population whereas assembly in G2 phase is never observed in control cells in which the nascent pool remained diffusely nuclear (Figures 1B, C, and S1A-C). Assembly under these transiently induced conditions in G2 phase resulted in stable incorporation of CENP-A into chromatin, as it is retained at centromeres on condensed mitotic chromosomes following Roscovitine washout ( Figure S2 ). However, a brief, 1 hour induction of CENP-A assembly in this phase is likely incomplete as normal CENP-A accumulation at centromeres continues for the duration of G1 phase [~10 hours (Lagana et al., 2010) ].
Roscovitine treatment of G2 cells did not change cell cycle position as treatment prevents mitotic entry and cyclin B levels remained high ( Figures 1B and S1D ).
Preservation of high cyclin B levels suggests that Roscovitine treated cells do not enter a precocious G1-like state by premature activation of APC mediated protein destruction.
Indeed, blocking global proteolysis by the proteasome inhibitor MG132 did not interfere with G2 induced CENP-A assembly. Similarly, treatment with Cycloheximide shows that de novo synthesis of proteins is not required for unscheduled CENP-A loading (Figures 1D and E) . These results argue against a role for APC-mediated destruction of a putative inhibitor of CENP-A assembly other than the Cdk activator cyclin B.
Unscheduled CENP-A assembly requires the canonical assembly factors
We next determined whether unscheduled CENP-A assembly induced in G2 phase resulted from the activation of the canonical CENP-A assembly pathway. Mis18α, Mis18β and the Myb-domain containing protein HsKNL2/M18BP1 are essential for CENP-A assembly in G1 phase and are recruited to centromeres during anaphase, just prior to the onset of CENP-A assembly (Silva and Jansen, 2009; Fujita et al., 2007; Maddox et al., 2007) . Strikingly, inhibition of Cdk activity in G2 cells resulted in rapid recruitment of GFP-Mis18α and HsKNL2/M18BP1 to centromeres (Figures 2A, B , and S3). Cells displayed either centromere localized GFP-Mis18α alone ( Figure 2A, red arrow) or both GFP-Mis18α and nascent CENP-A-SNAP (Figure 2A , green arrow) but never CENP-A-SNAP alone ( Figure 2B ). This suggests that, as for canonical G1 loading of CENP-A, Mis18α arrives prior to, and is required for subsequent CENP-A assembly under induced conditions in G2 phase. Consistently, depletion of Mis18α, HsKNL2/M18BP1 or the CENP-A specific chaperone HJURP (Dunleavy et al., 2009; Foltz et al., 2009 ) by siRNA treatment resulted in a reduction of both G1 phase assembly of nascent CENP-A as well as unscheduled assembly in G2 phase ( Figure 2C ).
Cdk1 and Cdk2 are sufficient to maintain cell cycle control of CENP-A assembly
Our small molecule inhibitor experiments indicate that prior to mitosis, the CENP-A assembly machinery is present but kept in an inactive state by Cdk activity. The predominant Cdks that are active during G2 phase are Cdk2 and Cdk1, both of which are naturally deactivated upon mitotic entry and mitotic exit, respectively (Pines, 2006) , and both of which are strongly inhibited by Roscovitine and Purvalanol A (WesierskaGadek and Krystof, 2009). However, due to the broad substrate specificity of pan-Cdk inhibitors (Wesierska-Gadek and Krystof, 2009), we cannot determine which Cdk (if any) is responsible for controlling CENP-A assembly. To address this directly we turned to chicken DT40 cells that harbor defined mutations in Cdk1 and Cdk2. We utilized cells that carry either a homozygous Cdk2 deletion (cdk2 -/-) and/or express analogue sensitive Cdk1 in a homozygous cdk1 null background, which can be selectively inhibited by addition of the ATP analog 1NM-PP1 (cdk1as) (Hochegger et al., 2007) .
1NM-PP1 does not affect cell cycle progression of wild type DT40 cells, underscoring the specificity to the cdk1as mutation [data not shown and (Hochegger et al., 2007) ]. Figure 1A and (Jansen et al., 2007; Hemmerich et al., 2008) ] and fly embryos (Schuh et al., 2007) , chicken DT40 cells assemble CENP-A at centromeres only upon mitotic exit. Cdk2 is non essential in DT40 cells (Hochegger et al., 2007) and mice (Berthet et al., 2003; Ortega et al., 2003) possibly due to compensation by cyclin A and E mediated Cdk1 activity (Hochegger et al., 2007; Santamaría et al., 2007) . Consistently, timing of assembly did not change in the cdk2 -/-mutant background ( Figures 3A and B) , indicating that inhibition of Cdk2 alone is not sufficient to induce unscheduled CENP-A assembly. To test for the involvement of Cdk1 we synchronized cdk1as single or cdk1as/cdk2 -/-double mutants in low (1 μM) levels of 1NM-PP1. At these concentrations Cdk1 activity is sufficient to drive S phase progression but not high enough to allow entry into mitosis resulting in a G2 arrest.
These cells were either maintained in G2 in low inhibitor concentrations, or released into G1 phase by inhibitor removal, or shifted to high (10 μM) doses of ATP analogue to completely abolish Cdk1activity. While CENP-A assembly in G1 was normal in cells of either genotype that were released from the G2 arrest, cdk1as single mutants showed little centromere assembly in G2 (Figures 3C´ and D) . Strikingly, G2 arrested cdk1as/cdk2 -/-double mutants readily incorporated CENP-A at centromeres in virtually all cells in both low and high 1NM-PP1 concentrations (Figures 3C and D) . Clearly, loss of both Cdk1 and Cdk2 is sufficient to induce premature CENP-A loading, which indicates these activities are responsible for suppressing the CENP-A assembly machinery prior to mitotic exit.
CENP-A assembly can be induced in S phase
Assembly of CENP-A occurs even at low doses of 1NM-PP1 in cdk1as/cdk2 -/-cells which maintain sufficient Cdk1 activity to progress through S phase [ Figure S4A and (Hochegger et al., 2007) 
Discussion
Our combined results demonstrate that the CENP-A assembly machinery is present and poised for activity throughout most of the cell cycle, but is kept in an inactive state by Cdk1 and Cdk2 activities until completion of DNA replication and chromosome segregation. We further demonstrate that the only aspect of mitotic passage that is essential for subsequent CENP-A assembly is the resulting loss of mitotic Cdk activity.
Because APC-mediated destruction of proteins, other than the Cdk1 activator Cyclin B, is not required for CENP-A assembly we argue that the trigger initiating assembly likely depends directly on a phospho-switch mediated by overlapping Cdk1 and Cdk2 kinase activity.
Several implications follow from these findings. First, as outlined in Figure 4D , our results provide a logical explanation for the cell cycle coupling between DNA replication, mitosis and CENP-A assembly. The recently identified CENP-T/CENP-W complex specifically and functionally interacts with histone H3 containing nucleosomes directly adjacent to CENP-A nucleosomes (Hori et al., 2008; Ribeiro et al., 2010) , suggesting that neighboring H3 and CENP-A nucleosomes make up an integral part of the centromeric complex. Importantly, such a mixed H3/CENP-A mitotic chromatin state can only be achieved by delaying assembly of CENP-A until after mitosis, providing a possible explanation for the temporal disconnect between DNA replication and CENP-A loading. Second, since inhibition of CENP-A loading requires a higher Cdk activity threshold compared to S phase entry it is possible that cells are permissive for CENP-A assembly throughout G1 up to early S phase where cyclin A associated Cdk activity is still low. We propose that the Cdk mediated molecular switch that turns the CENP-A assembly machinery ´ON´ in early G1 and then ´OFF´ after S phase entry is one and same. This temporal restriction of CENP-A assembly activity during G1 may represent an important mechanism to maintain a proper centromere size.
Experimental procedures Cell lines and constructs
HeLa cells and their derivatives were cultured in DMEM medium (Gibco) supplemented with 10% newborn calf serum (Gibco) at 37°C 5% CO2. A HeLa cell line stably expressing both CENP-A-SNAP and LAP-(GFP)-Mis18α was generated using the previous established stable cell line expressing CENP-A-SNAP (Jansen et al., 2007) containing an additional triple HA tag at its N-terminus. The resulting 3xHA-SNAP-CENP-A fusion protein (referred to as SNAP-CENP-A throughout this paper) was subcloned into p3XFLAG-CMV-14 (Sigma) (including a STOP codon, excluding FLAG from the ORF). DT40 cell lines were cultured in RPMI1640 medium (Gibco) supplemented with 50 μM β-mercaptoethanol, 10% fetal bovine serum (Gibco) and 1% chicken serum (Gibco) at 39°C, 5%CO2. Stable lines expressing SNAP-CENP-A were created in DT40 cdk1as and cdk1as/cdk2 -/-backgrounds (Hochegger et al., 2007) by electroporation with a Gene Pulser apparatus (BioRad) at 550 V and 25 μF as described (Sonoda et al., 1998) . Puromycin (0,5 µg/mL, Calbiochem) and Zeocin (500 µg/mL, Invivogen) were used to select cdk1as and cdk1as/cdk2 -/-cell lines respectively. Clonal lines expressing SNAP-CENP-A at sub-endogenous levels were selected by fluorescence microscopy after TMR-Star labeling and by western-blot using an anti-chicken CENP-A antibody (Gift from T. Fukagawa, NIG, Mishima, Japan).
Cell synchronization and drug treatments
HeLa cells were synchronized by a double thymidine block. Cells were treated with thymidine (2 mM, Sigma) for 17 h, washed twice in medium and released in medium containing deoxycytidine (24 µM, Sigma) for 9 h. Subsequently, cells were treated again with thymidine for 16h, and finally released into medium containing deoxycytidine and assayed. Roscovitine, Purvalanol A, MG132 and Cyclohexamide (Sigma) were used at 100 µM, 25 µM, 24 µM, 10 µg/mL respectively. DMSO (Sigma) was used in control conditions. DT40 cells were treated with 1 µM or 10 µM of 1NM-PP1 (synthesized by Chris Larch and Hansjoerg Streicher, Sussex University, UK) for partial or strong inhibition of cdk1as activity, respectively. DT40 cells were synchronized with 100 ng/mL Nocodazole or 2 mM Hydroxyurea (HU) (both from Sigma).
SNAP quench-chase-pulse labeling
HeLa cells expressing CENP-A-SNAP were pulse labeled by addition of 2 µM BTP (Covalys) in growth medium for 30 min at 37°C, 5% CO2, for irreversible, nonfluorescent labeling of pre-existing SNAP pool . We refer to this step as "quench". Products, Inc.) antibodies at dilution of 1:3000 and 1:1000, respectively. Anti-mouse and anti-rabbit HRP-conjugated secondary antibodies were purchased from Jackon
Immunoresearch Laboratories.
Microscopy
Digital images were captured using a DeltaVision Core system (Applied Precision) that controls an inverted microscope (Olympus, IX-71), coupled to a Cascade2 EMCCD camera (Photometrics). 512 x 512 images were collected at 1x binning using a 100x oil objective (NA 1.40, UPlanSApo) with 0.2 µm z sections scanning the entire nucleus.
Images were subsequently deconvolved and maximum signals were projected as 2D images using softWoRx (Applied Precision). Centromeric TMR intensity was quantified on non-deconvolved, maximum projection images by placing a 7 x 7 pixel square on each centromere using an unrelated centromere marker (CENP-T 
